Philips and Paige Team Up to Bring Artificial Intelligence (AI) to Clinical Pathology Diagnostics

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Paige, a leader in computational pathology, announced a strategic collaboration to deliver clinical-grade AI applications to pathology laboratories. These AI technologies, starting with Paige Prostate, aim to help pathologists identify, quantify and characterize cancer in tissue samples and make precise diagnoses more efficiently.
Source: eHealth News EU - Category: Information Technology Tags: Featured Philips Business and Industry Source Type: news